Target intelligence / Profile preview

Ras-related GTP-binding protein A (RRAGA)

Target
RRAGA
Molecular classification
Small GTPase, GTP-binding protein, mTOR signaling pathway regulator, Molecular switch
01

Overview

Ras-related GTP-binding protein A (RRAGA) is a member of the Rag family of small GTPases, functioning as a molecular switch that plays a central role in nutrient sensing and regulation of the mammalian target of rapamycin complex 1 (mTORC1) pathway. In its active GTP-bound form, RRAGA forms heterodimers with RRAGC or RRAGD and recruits mTORC1 to the lysosomal membrane in response to amino acid availability, enabling mTORC1 activation and downstream signaling that regulates cell growth, proliferation, and metabolism. RRAGA also interacts with ubiquitin ligases and is targeted by viral proteins, such as adenovirus E3-14.7K, influencing immune signaling and apoptosis. Dysregulation of RRAGA has been implicated in cancer and metabolic diseases due to its pivotal role in mTORC1 signaling

Other names
Ras-related GTP-binding protein ARRAGARagARAGAFIP-1Adenovirus E3 14.7 kDa-interacting protein 1FIP1rag Aras-related GTP-binding protein Aadenovirus E3-14.7K interacting protein 1
02

Mechanism of action

Drugs targeting this molecule would likely modulate mTORC1 activity by regulating the nucleotide-bound state of RRAGA or its interaction with mTORC1 pathway components, affecting cell growth, proliferation, and metabolism

03

Biological functions

GTP bindingProtein dimerizationRegulation of mTORC1 signalingCellular response to amino acid availabilityRecruitment of mTORC1 to lysosomesApoptosis/cell death signalingInteraction with ubiquitin protein ligases
04

Disease associations

CancerCataractCombined oxidative phosphorylation deficiency 8Other diseases involving mTOR pathway dysregulation
05

Safety considerations

Potential for widespread effects on cell growth and metabolism due to central regulatory role in mTORC1 signalingRisk of immune, metabolic, or cell death pathway dysregulation
06

Biomarkers

No established clinical biomarkers for patient selection or monitoring based specifically on RRAGA, though mTOR pathway activity is widely used in research

Beyond the preview

Go deeper on Ras-related GTP-binding protein A (RRAGA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ras-related GTP-binding protein A (RRAGA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call